Prothena Corp Public (PRTA) Total Liabilities (2012 - 2026)
Prothena Corp Public (PRTA) recorded quarterly Total Liabilities of $37.3 million in Q1 2026, down 19.54% quarter-over-quarter from $46.3 million in Q4 2025, and down 35.34% on a YoY basis from $57.7 million in Q1 2025.
Prothena Corp Public (PRTA) Total Liabilities (2012 - 2026) Analysis & Trends
Prothena Corp Public's Total Liabilities history runs 15 years deep, the most recent figure standing at $37.3 million for Q1 2026.
- In Q1 2026, Total Liabilities fell 35.34% year-over-year to $37.3 million; the TTM figure through Mar 2026 stood at $37.3 million (down 35.34% YoY), while the FY2025 annual figure was $46.3 million, down 23.02% from the prior year.
- Total Liabilities was $37.3 million for Q1 2026 at Prothena Corp Public, down from $46.3 million in the prior quarter.
- In the past five years, Total Liabilities ranged from a high of $149.8 million in Q3 2022 to a low of $37.3 million in Q1 2026.
- Historically, Total Liabilities has averaged $99.3 million across 5 years, with a median of $120.8 million in 2024.
- The sharpest annual moves came in 2024 and 2025: Total Liabilities slumped 55.43% in 2024, then climbed 17.42% in 2025.
- A 5-year view of Total Liabilities shows it stood at $136.0 million in 2022, then dropped by 0.72% to $135.0 million in 2023, then plunged by 55.43% to $60.2 million in 2024, then decreased by 23.02% to $46.3 million in 2025, then declined by 19.54% to $37.3 million in 2026.
- The last three Total Liabilities figures came in at $37.3 million (Q1 2026), $46.3 million (Q4 2025), and $57.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 1.74 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 15.48 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 16.35 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 731.60 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 10.44 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 19.51 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 943,068.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 7.12 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 137.56 Mn |
| 10 | Prothena Corp Public | 479.08 Mn | 149.61 Mn | - | 37.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 37.28 Mn |
| Dec 31, 2025 | 46.33 Mn |
| Sep 30, 2025 | 57.64 Mn |
| Jun 30, 2025 | 74.74 Mn |
| Mar 31, 2025 | 57.66 Mn |
| Dec 31, 2024 | 60.18 Mn |
| Sep 30, 2024 | 60.89 Mn |
| Jun 30, 2024 | 63.65 Mn |
| Mar 31, 2024 | 120.80 Mn |
| Dec 31, 2023 | 135.02 Mn |
| Sep 30, 2023 | 129.69 Mn |
| Jun 30, 2023 | 138.97 Mn |
| Mar 31, 2023 | 134.18 Mn |
| Dec 31, 2022 | 135.99 Mn |
| Sep 30, 2022 | 149.79 Mn |
| Jun 30, 2022 | 142.29 Mn |
| Mar 31, 2022 | 142.53 Mn |
| Dec 31, 2021 | 143.32 Mn |
| Sep 30, 2021 | 142.23 Mn |
| Jun 30, 2021 | 148.17 Mn |